IFACX
Price
$27.03
Change
+$0.08 (+0.30%)
Updated
Jun 2 closing price
Net Assets
146.54B
IVIPX
Price
$33.67
Change
+$0.21 (+0.63%)
Updated
Jun 2 closing price
Net Assets
461.84M
Interact to see
Advertisement

IFACX vs IVIPX

Header iconIFACX vs IVIPX Comparison
Open Charts IFACX vs IVIPXBanner chart's image
IFACX vs IVIPX Comparison Chart in %
View a ticker or compare two or three
VS
IFACX vs. IVIPX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IFACX is a Buy and IVIPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
IFACX has more cash in the bank: 147B vs. IVIPX (462M). IFACX pays higher dividends than IVIPX: IFACX (2.83) vs IVIPX (1.16). IFACX was incepted earlier than IVIPX: IFACX (25 years) vs IVIPX (17 years). IFACX (1.31) and IVIPX (1.31) have similar cost to investors . IVIPX is a more actively managed with annual turnover of: 126.00 vs. IFACX (65.00). IVIPX has a lower initial minimum investment than IFACX: IVIPX (0) vs IFACX (250). IFACX annual gain was more profitable for investors over the last year : 8.03 vs. IVIPX (-16.85). IFACX return over 5 years is better than : 17.87 vs. IVIPX (-27.90).
IFACXIVIPXIFACX / IVIPX
Total Expense Ratio1.311.02128%
Annual Report Gross Expense Ratio1.311.31100%
Fund Existence25 years17 years-
Gain YTD5.6715.220109%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets147B462M31,818%
Annual Yield % from dividends2.831.16243%
Returns for 1 year8.03-16.85-48%
Returns for 3 years33.08-10.67-310%
Returns for 5 years17.87-27.90-64%
Returns for 10 years51.11-4.69-1,091%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXTR29.461.33
+4.73%
Extreme Networks
PRQR1.480.06
+4.23%
ProQR Therapeutics NV
STRL875.5230.13
+3.56%
Sterling Infrastructure
VVOS0.66-0.02
-3.50%
Vivos Therapeutics
GERN1.16-0.05
-4.13%
Geron Corp